Compliance, Patient
Conditions
Keywords
Telehealth, automated peritoneal dialysis
Brief summary
This study is to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis by using automated peritoneal dialysis with SHARESOURCE software, and to evaluate if telemonitoring can improve peritoneal dialysis compliance and outcomes in the observation period.
Detailed description
The non-compliance of patients receiving automated peritoneal dialysis (APD) is around 10-20%, and was believed to be under-estimated. Recently, a two-way telehealth system, SHARESOURCE software, provide practitioners real-time monitoring and recording of the therapy of APD. By using this APD with SHARESOURCE software, we want to investigate the non-compliance rate of patients undergoing automated peritoneal dialysis, want to see if it can improve peritoneal dialysis compliance and outcomes in the observation period.
Interventions
DEVICEHomeChoice Claria APD machine with SHARESOURCE
HomeChoice Claria APD machine with SHARESOURCE software. SHARESOURCE is a software can telemonitor patients' compliance
Sponsors
E-DA Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
use automated peritoneal dialysis machine without SHARESOURCE for 12 weeks, then use automated peritoneal dialysis machine with SHARESOURCE for 12 weeks
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* stable received peritoneal dialysis for over 1 year. Use automated peritoneal dialysis machine regularly by him/herself.
Exclusion criteria
* Acute hospitalization events due to acute coronary syndrome, stroke, heart failure, liver cirrhosis, systemic infection in 1 month. * Life expectancy \<1 year * Peritoneal dialysis prescriptions will be scheduled or expected to change in 3 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of baseline patients' non-compliance rate at 3 months | baseline(between week 0 and 12) and 3 months(week 12 and week 24) | Non compliance rate was calculated by the days of non-compliance divided by days of APD therapy |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change of baseline uremic toxin level at 3 and 6 months | baseline, week 12 and week 24 | concentration of uremic toxins(ex: indoxyl sulfate, and p-cresyl sulfate) |
| change of body composition analysis | baseline, week 12 and week 24 | body composition exam (Body Composition Monitor, Fresenius Medical Care, Bad Homburg, Germany) will be done |
| Change of baseline peritoneal dialysis adequacy at 3 and 6 months | baseline, week 12 and week 24 | Dialysis adequacy is to see if dialysis is enough |
| Hospitalization rate | follow up to week 60 | calculate the number of hospitalization rate |
| Change of telephone contact frequency | baseline(between week 0 and 12) and 3 months(week 12 and week 24) | the telephone contact frequency (from patient to nurse) for peritoneal dialysis-related problems will be collected |
| peritonitis rate (patient-month) | follow up to week 60 | calculate the number of peritonitis rate |
Contacts
Primary ContactShih-Yuan Hung
Outcome results
None listed